Masimo Corporation (MASI)

184,54 +6,00 (+3,36%) Alla chiusura: 04:00PM EDT

Masimo Corporation

52 Discovery
Irvine, CA 92618
United States
949 297 7000
https://www.masimo.com

Settore/i: Healthcare
Settore: Medical Instruments & Supplies
Impiegati a tempo pieno: 2.200

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Joseph E. Kiani	Founder, CEO & Chairman	4,22M	N/D	1965
Mr. Micah Young	Exec. VP of Fin. & CFO	773,81k	317,33k	1979
Mr. Bilal Muhsin	Chief Operating Officer	986,31k	N/D	1981
Mr. Thomas Samuel McClenahan	Exec. VP, Gen. Counsel & Corp. Sec.	774,53k	N/D	1973
Mr. Tao Leopold Levy	Exec. VP of Bus. Devel.	631,6k	N/D	1974
Mr. Yongsam Lee	Exec. VP & Chief Information Officer	N/D	N/D	1965
Dr. Steven J. Barker	Chairman of Scientific Advisory Board & Chief Science Officer	N/D	N/D	1945
Mr. Eli Kammerman	VP of Bus. Devel. & Investor Relations	N/D	N/D	N/D
Mr. Jon Coleman	Pres of Worldwide Sales, Professional Services & Medical Affairs	N/D	N/D	1964
Mr. Anand Sampath	Exec. VP of Operations & Clinical Research	N/D	N/D	1966

Gli importi risalgono al giorno 31 dicembre 2021 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.

Governance aziendale

L'ISS Governance QualityScore di Masimo Corporation al 1 febbraio 2023 è 6. I criteri di valutazione fondamentali sono revisione: 3; Consiglio di Amministrazione: 7; diritti degli azionisti: 7; retribuzione: 5.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.